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ase error at the nucleotide site bearing the mutation. In
targeted NGS, synthetic competitive IS control for sto-
chastic sampling at input of both target into library
preparation and of target library product into sequencer,
enable reduced sequencing space requirement, and con-
trol for qualitative errors generated during library
preparation and sequencing. These controls enable ac-
curate clinical diagnostic reporting of conﬁdence limits
and limit of detection for copy number measurement, and
reduce sequencing space required for analysis.Characteristics, oncogene dependency,
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Lung cancer is molecularly heterogeneous characterized
by various genetic alterations. Many targetable mutations
in lung adenocarcinoma occur at low frequencies, which
limits timely recruitment of patients in clinical trials of
precision therapy. Thus, preclinical animal models are
invaluable for evaluation of novel targeted drugs.
Recurrent RET fusions have been found in 1-2% of non-
small cell lung cancer (NSCLC). Among them KIF5B-RET
fusion is the most prevalent. To develop an animal model
for evaluation of KIF5B-RET fusion in lung adenocarci-
noma, we generated transgenic mice containing a doxy-
cycline-inducible tetO-KIF5B-RET transgene. Induction of
CCSP-rtTA/tetO-KIF5B-RET bitransgenic mice with
doxycycline resulted in MRI- and CT-detectable lung
adenocarcinoma in 4-5 months. KIF5B-RET-induced lung
adenocarcinoma is characterized by desmoplastic reac-
tion. Desmoplasia is associated with invasive lung
adenocarcinoma and is found in human RET-fusion-pos-
itive lung adenocarcinoma, but it has not been observed
in transgenic mouse models of EGFRL858R-, KrasG12D-, or
PTPN11E76K-induced lung adenocarcinoma. Using MRI,
CT, and histological examinations, we evaluated onco-
gene dependence and the response to the multikinase
RET inhibitor ponatinib in KIF5B-RET-induced lung tu-
mors. Tumors regressed one month after Dox withdrawal
or ponatinib treatment. Thus, we have established a
transgenic mouse model of KIF5B-RET-induced lung
adenocarcinoma. The KIF5B-RET-induced lung tumorsare associated with desmoplasia, dependent on KIF5B-
RET for maintaining the malignant phenotype, and
respond to ponatinib treatment.
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Mark W. Onaitis Duke University, Durham, NCWe have previously used cell lineage speciﬁc CreER mouse
models to identify Type II cells as the cell-of-origin of
KrasG12D induced lung adenocarcinoma.Using gain and loss
of function genetic models, we discovered the active Notch
signaling and low Sox2 dictate the ability of type II cells to
proliferate and progress into adenocarcinoma upon
KrasG12Dactivation.Hereweprovided further evidence that
Notch signaling is required for KrasG12D induced Type II
cells into a biopotent embryonic state. These SpcþRageþ
cells express speciﬁc lung embryonic development marker
Sox9 and Ezh2. Additionally, genetical and chemical Sox2
upregulation profoundly inhibits KrasG12D-induced lung
tumor formation inType II cells. Sox2-expressingType II cells
are unable to dedifferentiating Type II cells when Kras is
activated. Inconclusion,ourdatasuggestKrascanspeciﬁcally
transform Type II cells into lung adenocarcinoma by dedif-
ferentiating Type II cells into SpcþRageþ bipotent embry-
onic progenitor cells through activated Notch signaling.
Unregulated Sox2 can alter Type II cells to proximal cell state,
with subsequent loss of ability to dedifferentiate into these
bipotent embryonic cells. Our ﬁndings could provide a new
therapeutic strategy to target Kras activated lung cancer.ROR1 functions as a scaffold of
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